Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Research Podcast Cover

    Episode 23: Clinical Applications of Biomarkers and Large-Scale Collaborative Research with Charles Adler

    Dr. Charles (Chuck) Adler shares his perspectives on how biomarkers are currently being used in clinical and research contexts, and what it would take for him to use them more often in clinical…
    Learn more
  • Three people looking at a computer screen

    FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials for Parkinson’s and Related Diseases

    FDA supports the use of alpha-synuclein seed amplification assay (αSyn-SAA) biomarker for Parkinson's clinical trials and drug development.
    Learn more
  • Research Podcast Cover

    Episode 22: Investigating Light Therapy For Sleep and Motor Function in People with PD with Beatrix Feigl

    Dr. Beatix Feigl discusses the results of a recent randomized controlled trial evaluating the efficacy of this melanopsin photoreceptor-directed light therapy on sleep and circadian rhythm, as well…
    Learn more
  • Two researchers in a lab

    What We Fund: $69.1M Toward Novel Efforts to Improve Mobility and Target Cellular Mechanisms Underlying PD

    The Michael J. Fox Foundation (MJFF) announces 45 grants that total more than $69.1 million awarded in June and July 2024.
    Learn more
  • Research Podcast Cover

    Episode 21: The Autophagy-Lysosomal Pathway and Development of Relevant PD Biomarkers with Zhenyu Yue

    Dr. Zhenyu Yue discusses his research on Parkinson's and neurodegenerative diseases, focusing on the autophagy-lysosomal pathway, potential therapies, and MJFF-funded efforts to develop assays…
    Learn more
  • Policy Forum in DC in 2017

    With Renewed Optimism: A Patient Advisor’s Hopeful Perspective on Parkinson’s Research

    Kevin Kwok, a Parkinson’s advocate, wrote that PD drug development is like “cave exploration in the dark,” but now we have the lantern we need. Read more.
    Learn more
  • Common Questions from Our Webinar on Parkinson's Medications

    FDA approves new levodopa/carbidopa formulation for use in Parkinson’s

    The U.S. Food and Drug Administration (FDA) has approved a new medication for the treatment of Parkinson's disease. Crexont aims to offer patients improved symptom control and a better quality…
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.